featured
Avelumab Maintenance After First-line Induction Chemotherapy vs Continuation of Chemotherapy in Gastric Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase III Trial of Avelumab Maintenance After First-Line Induction Chemotherapy Versus Continuation of Chemotherapy in Patients With Gastric Cancers: Results From JAVELIN Gastric 100
J. Clin. Oncol 2020 Nov 16;[EPub Ahead of Print], M Moehler, M Dvorkin, N Boku, M Özgüroğlu, MH Ryu, AS Muntean, S Lonardi, M Nechaeva, AC Bragagnoli, HS Coşkun, A Cubillo Gracian, T Takano, R Wong, H Safran, GM Vaccaro, ZA Wainberg, MR Silver, H Xiong, J Hong, J Taieb, YJ BangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.